Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Rheumatoid Arthritis
What is your approach to a patient with rheumatoid arthritis and moderate disease activity on 25 mg of PO methotrexate?
Do you switch to SQ MTX, or is it best to add tx, such as a TNFi?
Answer from: at Community Practice
Switching to sub cu may work for low disease activity, but not moderate.
Sign in or Register to read more
10978
Related Questions
How do you approach methotrexate management around vaccines other than COVID and influenza?
What would be your approach to a patient with new diagnosis of seropositive rheumatoid arthritis manifesting as a constrictive pericarditis with no joint pain complaints?
How do you approach managing nausea and GI side effects when initiating methotrexate?
Can you use leflunomide and rituximab in a patient with both multiple sclerosis and rheumatoid arthritis?
Would you add abatacept to treat active inflammatory arthritis in a patient with history of RA-ILD who is already taking mycophenolate?
How you do approach treatment for a patient with active seropositive RA (+RF/+CCP) who is receiving treatment for Hepatitis C?
Can JAK inhibitors for established rheumatoid arthritis be continued when starting an immune checkpoint inhibitor?
Would you continue Jak inhibitor therapy in a patient with long standing, previously refractory RA in their 60s who was found to have stenosis of the left common femoral artery and no other history of arteriosclerotic disease?
Do you avoid JAK inhibitors in patients with a history of liver disease including NAFLD or cirrhosis?
How do you approach venous insufficiency management in patients on Jak inhibitors?